The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Betahistine Market Research Report 2025
Synopsis
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.
The global Betahistine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Betahistine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Betahistine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, EA Pharma Co., Ltd., Disphar International B.V., HENNIG ARZNEIMITTEL GmbH & Co. KG, DOC Generici, Ciclum Farma Unipessoal and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Betahistine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Betahistine.
Report Scope
The Betahistine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Betahistine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Betahistine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
Segment by Type
8mg
25mg
Others
Segment by Application
Cerebral Thrombosis
Cerebral Embolism
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Betahistine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.
The global Betahistine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Betahistine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Betahistine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, EA Pharma Co., Ltd., Disphar International B.V., HENNIG ARZNEIMITTEL GmbH & Co. KG, DOC Generici, Ciclum Farma Unipessoal and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Betahistine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Betahistine.
Report Scope
The Betahistine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Betahistine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Betahistine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
Segment by Type
8mg
25mg
Others
Segment by Application
Cerebral Thrombosis
Cerebral Embolism
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Betahistine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Betahistine Market Overview
1.1 Product Overview and Scope of Betahistine
1.2 Betahistine Segment by Type
1.2.1 Global Betahistine Market Value Comparison by Type (2024-2030)
1.2.2 8mg
1.2.3 25mg
1.2.4 Others
1.3 Betahistine Segment by Application
1.3.1 Global Betahistine Market Value by Application: (2024-2030)
1.3.2 Cerebral Thrombosis
1.3.3 Cerebral Embolism
1.3.4 Others
1.4 Global Betahistine Market Size Estimates and Forecasts
1.4.1 Global Betahistine Revenue 2019-2030
1.4.2 Global Betahistine Sales 2019-2030
1.4.3 Global Betahistine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Betahistine Market Competition by Manufacturers
2.1 Global Betahistine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Betahistine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Betahistine Average Price by Manufacturers (2019-2024)
2.4 Global Betahistine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Betahistine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Betahistine, Product Type & Application
2.7 Betahistine Market Competitive Situation and Trends
2.7.1 Betahistine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Betahistine Players Market Share by Revenue
2.7.3 Global Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Betahistine Retrospective Market Scenario by Region
3.1 Global Betahistine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Betahistine Global Betahistine Sales by Region: 2019-2030
3.2.1 Global Betahistine Sales by Region: 2019-2024
3.2.2 Global Betahistine Sales by Region: 2025-2030
3.3 Global Betahistine Global Betahistine Revenue by Region: 2019-2030
3.3.1 Global Betahistine Revenue by Region: 2019-2024
3.3.2 Global Betahistine Revenue by Region: 2025-2030
3.4 North America Betahistine Market Facts & Figures by Country
3.4.1 North America Betahistine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Betahistine Sales by Country (2019-2030)
3.4.3 North America Betahistine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Betahistine Market Facts & Figures by Country
3.5.1 Europe Betahistine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Betahistine Sales by Country (2019-2030)
3.5.3 Europe Betahistine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Betahistine Market Facts & Figures by Country
3.6.1 Asia Pacific Betahistine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Betahistine Sales by Country (2019-2030)
3.6.3 Asia Pacific Betahistine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Betahistine Market Facts & Figures by Country
3.7.1 Latin America Betahistine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Betahistine Sales by Country (2019-2030)
3.7.3 Latin America Betahistine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Betahistine Market Facts & Figures by Country
3.8.1 Middle East and Africa Betahistine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Betahistine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Betahistine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Betahistine Sales by Type (2019-2030)
4.1.1 Global Betahistine Sales by Type (2019-2024)
4.1.2 Global Betahistine Sales by Type (2025-2030)
4.1.3 Global Betahistine Sales Market Share by Type (2019-2030)
4.2 Global Betahistine Revenue by Type (2019-2030)
4.2.1 Global Betahistine Revenue by Type (2019-2024)
4.2.2 Global Betahistine Revenue by Type (2025-2030)
4.2.3 Global Betahistine Revenue Market Share by Type (2019-2030)
4.3 Global Betahistine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Betahistine Sales by Application (2019-2030)
5.1.1 Global Betahistine Sales by Application (2019-2024)
5.1.2 Global Betahistine Sales by Application (2025-2030)
5.1.3 Global Betahistine Sales Market Share by Application (2019-2030)
5.2 Global Betahistine Revenue by Application (2019-2030)
5.2.1 Global Betahistine Revenue by Application (2019-2024)
5.2.2 Global Betahistine Revenue by Application (2025-2030)
5.2.3 Global Betahistine Revenue Market Share by Application (2019-2030)
5.3 Global Betahistine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 TOWA PHARMACEUTICAL CO., LTD
6.1.1 TOWA PHARMACEUTICAL CO., LTD Corporation Information
6.1.2 TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
6.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio
6.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments/Updates
6.2 Nichi-Iko Pharmaceutical
6.2.1 Nichi-Iko Pharmaceutical Corporation Information
6.2.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nichi-Iko Pharmaceutical Betahistine Product Portfolio
6.2.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceutical Company Limited
6.3.1 Takeda Pharmaceutical Company Limited Corporation Information
6.3.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Pharmaceutical Company Limited Betahistine Product Portfolio
6.3.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.4 EA Pharma Co., Ltd.
6.4.1 EA Pharma Co., Ltd. Corporation Information
6.4.2 EA Pharma Co., Ltd. Description and Business Overview
6.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EA Pharma Co., Ltd. Betahistine Product Portfolio
6.4.5 EA Pharma Co., Ltd. Recent Developments/Updates
6.5 Disphar International B.V.
6.5.1 Disphar International B.V. Corporation Information
6.5.2 Disphar International B.V. Description and Business Overview
6.5.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Disphar International B.V. Betahistine Product Portfolio
6.5.5 Disphar International B.V. Recent Developments/Updates
6.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
6.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
6.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Business Overview
6.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio
6.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments/Updates
6.7 DOC Generici
6.6.1 DOC Generici Corporation Information
6.6.2 DOC Generici Description and Business Overview
6.6.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DOC Generici Betahistine Product Portfolio
6.7.5 DOC Generici Recent Developments/Updates
6.8 Ciclum Farma Unipessoal
6.8.1 Ciclum Farma Unipessoal Corporation Information
6.8.2 Ciclum Farma Unipessoal Description and Business Overview
6.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ciclum Farma Unipessoal Betahistine Product Portfolio
6.8.5 Ciclum Farma Unipessoal Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Betahistine Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Orion Corporation
6.10.1 Orion Corporation Corporation Information
6.10.2 Orion Corporation Description and Business Overview
6.10.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Orion Corporation Betahistine Product Portfolio
6.10.5 Orion Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Betahistine Industry Chain Analysis
7.2 Betahistine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Betahistine Production Mode & Process
7.4 Betahistine Sales and Marketing
7.4.1 Betahistine Sales Channels
7.4.2 Betahistine Distributors
7.5 Betahistine Customers
8 Betahistine Market Dynamics
8.1 Betahistine Industry Trends
8.2 Betahistine Market Drivers
8.3 Betahistine Market Challenges
8.4 Betahistine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Betahistine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Betahistine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Betahistine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Betahistine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Betahistine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Betahistine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Betahistine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Betahistine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Betahistine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Betahistine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Betahistine, Product Type & Application
Table 12. Global Key Manufacturers of Betahistine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Betahistine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Betahistine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Betahistine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Betahistine Sales by Region (2019-2024) & (K Units)
Table 18. Global Betahistine Sales Market Share by Region (2019-2024)
Table 19. Global Betahistine Sales by Region (2025-2030) & (K Units)
Table 20. Global Betahistine Sales Market Share by Region (2025-2030)
Table 21. Global Betahistine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Betahistine Revenue Market Share by Region (2019-2024)
Table 23. Global Betahistine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Betahistine Revenue Market Share by Region (2025-2030)
Table 25. North America Betahistine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Betahistine Sales by Country (2019-2024) & (K Units)
Table 27. North America Betahistine Sales by Country (2025-2030) & (K Units)
Table 28. North America Betahistine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Betahistine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Betahistine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Betahistine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Betahistine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Betahistine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Betahistine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Betahistine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Betahistine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Betahistine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Betahistine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Betahistine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Betahistine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Betahistine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Betahistine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Betahistine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Betahistine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Betahistine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Betahistine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Betahistine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Betahistine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Betahistine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Betahistine Sales (K Units) by Type (2019-2024)
Table 51. Global Betahistine Sales (K Units) by Type (2025-2030)
Table 52. Global Betahistine Sales Market Share by Type (2019-2024)
Table 53. Global Betahistine Sales Market Share by Type (2025-2030)
Table 54. Global Betahistine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Betahistine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Betahistine Revenue Market Share by Type (2019-2024)
Table 57. Global Betahistine Revenue Market Share by Type (2025-2030)
Table 58. Global Betahistine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Betahistine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Betahistine Sales (K Units) by Application (2019-2024)
Table 61. Global Betahistine Sales (K Units) by Application (2025-2030)
Table 62. Global Betahistine Sales Market Share by Application (2019-2024)
Table 63. Global Betahistine Sales Market Share by Application (2025-2030)
Table 64. Global Betahistine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Betahistine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Betahistine Revenue Market Share by Application (2019-2024)
Table 67. Global Betahistine Revenue Market Share by Application (2025-2030)
Table 68. Global Betahistine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Betahistine Price (US$/Unit) by Application (2025-2030)
Table 70. TOWA PHARMACEUTICAL CO., LTD Corporation Information
Table 71. TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
Table 72. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. TOWA PHARMACEUTICAL CO., LTD Betahistine Product
Table 74. TOWA PHARMACEUTICAL CO., LTD Recent Developments/Updates
Table 75. Nichi-Iko Pharmaceutical Corporation Information
Table 76. Nichi-Iko Pharmaceutical Description and Business Overview
Table 77. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Nichi-Iko Pharmaceutical Betahistine Product
Table 79. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 80. Takeda Pharmaceutical Company Limited Corporation Information
Table 81. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 82. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Takeda Pharmaceutical Company Limited Betahistine Product
Table 84. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 85. EA Pharma Co., Ltd. Corporation Information
Table 86. EA Pharma Co., Ltd. Description and Business Overview
Table 87. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. EA Pharma Co., Ltd. Betahistine Product
Table 89. EA Pharma Co., Ltd. Recent Developments/Updates
Table 90. Disphar International B.V. Corporation Information
Table 91. Disphar International B.V. Description and Business Overview
Table 92. Disphar International B.V. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Disphar International B.V. Betahistine Product
Table 94. Disphar International B.V. Recent Developments/Updates
Table 95. HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
Table 96. HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Business Overview
Table 97. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product
Table 99. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments/Updates
Table 100. DOC Generici Corporation Information
Table 101. DOC Generici Description and Business Overview
Table 102. DOC Generici Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. DOC Generici Betahistine Product
Table 104. DOC Generici Recent Developments/Updates
Table 105. Ciclum Farma Unipessoal Corporation Information
Table 106. Ciclum Farma Unipessoal Description and Business Overview
Table 107. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ciclum Farma Unipessoal Betahistine Product
Table 109. Ciclum Farma Unipessoal Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Betahistine Product
Table 114. Mylan Recent Developments/Updates
Table 115. Orion Corporation Corporation Information
Table 116. Orion Corporation Description and Business Overview
Table 117. Orion Corporation Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Orion Corporation Betahistine Product
Table 119. Orion Corporation Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Betahistine Distributors List
Table 123. Betahistine Customers List
Table 124. Betahistine Market Trends
Table 125. Betahistine Market Drivers
Table 126. Betahistine Market Challenges
Table 127. Betahistine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Betahistine
Figure 2. Global Betahistine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Betahistine Market Share by Type in 2023 & 2030
Figure 4. 8mg Product Picture
Figure 5. 25mg Product Picture
Figure 6. Others Product Picture
Figure 7. Global Betahistine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Betahistine Market Share by Application in 2023 & 2030
Figure 9. Cerebral Thrombosis
Figure 10. Cerebral Embolism
Figure 11. Others
Figure 12. Global Betahistine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Betahistine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Betahistine Sales (2019-2030) & (K Units)
Figure 15. Global Betahistine Average Price (US$/Unit) & (2019-2030)
Figure 16. Betahistine Report Years Considered
Figure 17. Betahistine Sales Share by Manufacturers in 2023
Figure 18. Global Betahistine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Betahistine Players: Market Share by Revenue in 2023
Figure 20. Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Betahistine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Betahistine Sales Market Share by Country (2019-2030)
Figure 23. North America Betahistine Revenue Market Share by Country (2019-2030)
Figure 24. United States Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Betahistine Sales Market Share by Country (2019-2030)
Figure 27. Europe Betahistine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Betahistine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Betahistine Revenue Market Share by Region (2019-2030)
Figure 35. China Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Betahistine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Betahistine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Betahistine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Betahistine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Betahistine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Betahistine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Betahistine by Type (2019-2030)
Figure 56. Global Betahistine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Betahistine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Betahistine by Application (2019-2030)
Figure 59. Global Betahistine Price (US$/Unit) by Application (2019-2030)
Figure 60. Betahistine Value Chain
Figure 61. Betahistine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
